Marsh, Deborah J.
University of Technology Sydney · The University of Sydney
7 papers on CoChatORCID 0000-0001-5899-4931
Most cited papers
- Verified
Genome-wide association study identifies novel breast cancer susceptibility loci
Easton, D. F., Pooley, K. A., Dunning, A. M., Pharoah, P. D. P., Thompson, D., Ballinger, D. G., Struewing, J. P., Morrison, J., Field, H., Luben, R., et al. (2007) · Nature
Genetic Associations and EpidemiologyBRCA gene mutations in cancer
Cited by 2,319
- Verified
Mutation spectrum and genotype-phenotype analyses in Cowden disease and Bannayan-Zonana syndrome, two hamartoma syndromes with germline PTEN mutation
Marsh, D. (1998) · Human Molecular Genetics
PI3K/AKT/mTOR signaling in cancerGenetic and rare skin diseases.
Cited by 653
- Verified
A HIF1α Regulatory Loop Links Hypoxia and Mitochondrial Signals in Pheochromocytomas
Dahia, P. L. M., Ross, K. N., Wright, M. E., Hayashida, C. Y., Santagata, S., Barontini, M., Kung, A. L., Sanso, G., Powers, J. F., Tischler, A. S., et al. (2005) · PLoS Genetics
Adrenal and Paraganglionic TumorsCancer, Hypoxia, and Metabolism
Cited by 443
- Verified
Comparison of Methodologies to Detect Low Levels of Hemolysis in Serum for Accurate Assessment of Serum microRNAs
Shah, J. S., Soon, P. S., & Marsh, D. J. (2016) · PLOS ONE
MicroRNA in disease regulationClinical Laboratory Practices and Quality Control
Cited by 216
- Verified
Novel succinate dehydrogenase subunit B (SDHB) mutations in familial phaeochromocytomas and paragangliomas, but an absence of somatic SDHB mutations in sporadic phaeochromocytomas
Benn, D. E., Croxson, M. S., Tucker, K., Bambach, C. P., Richardson, A. L., Delbridge, L., Pullan, P. T., Hammond, J., Marsh, D. J., & Robinson, B. G. (2003) · Oncogene
Adrenal and Paraganglionic TumorsMetabolism and Genetic Disorders
Cited by 108
- Verified
Three-dimensional modelling of ovarian cancer: from cell lines to organoids for discovery and personalized medicine
Yee, C., Dickson, K.-A., Muntasir, M. N., Ma, Y., & Marsh, D. J. (2022) · Frontiers in Bioengineering and Biotechnology
Ovarian cancer diagnosis and treatment3D Printing in Biomedical Research
Cited by 66
- Verified
PARP Inhibitors Display Differential Efficacy in Models of BRCA Mutant High-Grade Serous Ovarian Cancer
Dickson, K.-A., Xie, T., Evenhuis, C., Ma, Y., & Marsh, D. J. (2021) · International Journal of Molecular Sciences
PARP inhibition in cancer therapyBRCA gene mutations in cancer
Cited by 11
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free